Technical Analysis for AGL - Angle Plc

Grade Last Price % Change Price Change
B 113.5 0.00% 0.00
AGL closed unchanged on Friday, May 7, 2021, on 30 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical AGL trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Older End-of-Day Signals for AGL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 10 hours ago
10 DMA Support about 10 hours ago
Fell Below Previous Day's Low 10 days ago
Down 5% 10 days ago
Down 3% 10 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Angle Plc Description

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Monitoring Cancer Nature Medical Specialties Oncology Fluid Offers Products Clinical Medicine Blood Drug Development Tumor Medical Diagnostic Circulating Tumor Cell

Is AGL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 120.0
52 Week Low 37.15
Average Volume 731,631
200-Day Moving Average 64.26
50-Day Moving Average 90.53
20-Day Moving Average 104.06
10-Day Moving Average 112.50
Average True Range 6.17
ADX 27.03
+DI 22.29
-DI 17.86
Chandelier Exit (Long, 3 ATRs ) 101.48
Chandelier Exit (Short, 3 ATRs ) 100.52
Upper Bollinger Band 129.20
Lower Bollinger Band 78.92
Percent B (%b) 0.69
BandWidth 48.32
MACD Line 7.54
MACD Signal Line 7.45
MACD Histogram 0.089
Fundamentals Value
Market Cap 244.48 Million
Num Shares 215 Million
EPS -6.60
Price-to-Earnings (P/E) Ratio -17.20
Price-to-Sales 76.32
Price-to-Book 3.39
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 116.50
Resistance 3 (R3) 116.33 115.17 116.00
Resistance 2 (R2) 115.17 114.40 115.25 115.83
Resistance 1 (R1) 114.33 113.93 114.50 114.50 115.67
Pivot Point 113.17 113.17 113.25 113.25 113.17
Support 1 (S1) 112.33 112.40 112.50 112.50 111.33
Support 2 (S2) 111.17 111.93 111.25 111.17
Support 3 (S3) 110.33 111.17 111.00
Support 4 (S4) 110.50